Alberto A. Amarilla

2.8k total citations
60 papers, 1.2k citations indexed

About

Alberto A. Amarilla is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Insect Science. According to data from OpenAlex, Alberto A. Amarilla has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 30 papers in Public Health, Environmental and Occupational Health and 9 papers in Insect Science. Recurrent topics in Alberto A. Amarilla's work include Mosquito-borne diseases and control (29 papers), Viral Infections and Vectors (23 papers) and SARS-CoV-2 and COVID-19 Research (14 papers). Alberto A. Amarilla is often cited by papers focused on Mosquito-borne diseases and control (29 papers), Viral Infections and Vectors (23 papers) and SARS-CoV-2 and COVID-19 Research (14 papers). Alberto A. Amarilla collaborates with scholars based in Australia, Brazil and Paraguay. Alberto A. Amarilla's co-authors include Luíz Tadeu Moraes Figueiredo, Víctor Hugo Aquino, Alexander A. Khromykh, Gabriel I. Parra, Yin Xiang Setoh, Juliana Helena Chávez, Jaqueline Raymondi Silva, Daniel Watterson, Emilio E. Espínola and Naphak Modhiran and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alberto A. Amarilla

59 papers receiving 1.2k citations

Peers

Countries citing papers authored by Alberto A. Amarilla

Since Specialization

Citations

This map shows the geographic impact of Alberto A. Amarilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto A. Amarilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto A. Amarilla more than expected).

Fields of papers citing papers by Alberto A. Amarilla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto A. Amarilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto A. Amarilla. The network helps show where Alberto A. Amarilla may publish in the future.

Co-authorship network of co-authors of Alberto A. Amarilla

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto A. Amarilla. A scholar is included among the top collaborators of Alberto A. Amarilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto A. Amarilla. Alberto A. Amarilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity 2025 ·Nature Communications ·Summa Bibby, James Jung, (unknown), Alberto A. Amarilla, Natalee D. Newton, Connor A. P. Scott, (unknown), Yi Tian Ting, Morgan E. Freney, Benjamin Liang, Timothy Grant, Fasséli Coulibaly, Paul R. Young, Roy A. Hall, Jody Hobson‐Peters, Naphak Modhiran, Daniel Watterson	0
2	Establishment of a CPER reverse genetics system for Powassan virus defines attenuating NS1 glycosylation sites and an infectious NS1-GFP11 reporter virus 2023 ·mBio ·Jonas N. Conde, (unknown), (unknown), Yin Xiang Setoh, Alberto A. Amarilla, (unknown), (unknown), Elena E. Gorbunova, Daniel J. Salamango, Jorge L. Benach, Hwan Keun Kim, Erich R. Mackow	6
3	The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variant 2023 ·Glycobiology ·Cassandra L. Pegg, Naphak Modhiran, Rhys Parry, Benjamin Liang, Alberto A. Amarilla, Alexander A. Khromykh, Lucy Burr, Paul R. Young, Keith J. Chappell, Benjamin L. Schulz, Daniel Watterson	4
4	SARS‐CoV ‐2 triggers complement activation through interactions with heparan sulfate 2022 ·Clinical & Translational Immunology ·(unknown), Alberto A. Amarilla, John D. Lee, Eduardo A. Albornoz, Naphak Modhiran, Richard J. Clark, Vito Ferro, Mohit Chhabra, Alexander A. Khromykh, Daniel Watterson, Trent M. Woodruff	13
5	Zika virus noncoding RNA cooperates with the viral protein NS5 to inhibit STAT1 phosphorylation and facilitate viral pathogenesis 2022 ·Science Advances ·Andrii Slonchak, Xiaohui Wang, Julio Aguado, Julian D. J. Sng, (unknown), Morgan E. Freney, Kexin Yan, Francisco J. Torres, Alberto A. Amarilla, (unknown), Yin Xiang Setoh, Nias Y. G. Peng, Daniel Watterson, Ernst J. Wolvetang, Andreas Suhrbier, Alexander A. Khromykh	29
6	Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems 2022 ·Pharmaceutics ·Ahmed O. Shalash, Armira Azuar, (unknown), Naphak Modhiran, Alberto A. Amarilla, Benjamin Liang, Alexander A. Khromykh, Waleed M. Hussein, Keith J. Chappell, Daniel Watterson, Paul R. Young, Mariusz Skwarczyński, István Tóth	8
7	Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein 2022 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Vladimir Shalgunov, Umberto Maria Battisti, David Schwefel, Naphak Modhiran, Vasko Kramer, (unknown), (unknown), (unknown), Alberto A. Amarilla, Daniel Watterson, Alejandro Rojas‐Fernández, Matthias M. Herth	1
8	Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay 2021 ·Vaccines ·Ahmed O. Shalash, Armira Azuar, (unknown), Naphak Modhiran, Alberto A. Amarilla, Benjamin Liang, Alexander A. Khromykh, Daniel Watterson, Paul R. Young, István Tóth, Mariusz Skwarczyński	8
9	Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine 2021 ·Science Advances ·Christopher L. D. McMillan, (unknown), Adi Idris, Aroon Supramaniam, Naphak Modhiran, Alberto A. Amarilla, Ariel Isaacs, Stacey T. M. Cheung, Benjamin Liang, Helle Bielefeldt‐Ohmann, Armira Azuar, Dhruba Acharya, Gabrielle Kelly, Germain J. P. Fernando, Michael J. Landsberg, Alexander A. Khromykh, Daniel Watterson, Paul R. Young, Nigel A.J. McMillan, David A. Muller	32
10	No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing 2021 ·Cell Reports ·(unknown), Jay Rasmussen, Gabriela O. Bodea, Alberto A. Amarilla, Patricia Gerdes, Francisco J. Sánchez‐Luque, (unknown), Naphak Modhiran, Benjamin Liang, J Faivre, Ira W. Deveson, Alexander A. Khromykh, Daniel Watterson, Adam D. Ewing, Geoffrey J. Faulkner	30
11	Zika Virus sfRNA Plays an Essential Role in the Infection of Insects and Mammals 2020 ·SHILAP Revista de lepidopterología ·Andrii Slonchak, Leon E. Hugo, Morgan E. Freney, Alberto A. Amarilla, Sonja Hall‐Mendelin, Kexin Yan, Francisco J. Torres, Yin Xiang Setoh, Nias Y. G. Peng, (unknown), Andrew F. van den Hurk, Ernst J. Wolvetang, Andreas Suhrbier, Gregor J. Devine, Alexander A. Khromykh	1
12	Ilheus and Saint Louis encephalitis viruses elicit cross-protection against a lethal Rocio virus challenge in mice 2018 ·PLoS ONE ·Alberto A. Amarilla, Marcílio Jorge Fumagalli, Mário Luis Garcia de Figueiredo, Djalma S. Lima‐Junior, Nilton Nascimento Santos-Júnior, (unknown), (unknown), (unknown), (unknown), Vanessa Danielle Menjon Müller, David F. Cólon, João Paulo Mesquita Luiz, Andreas Suhrbier, Yin Xiang Setoh, Alexander A. Khromykh, Luíz Tadeu Moraes Figueiredo, Víctor Hugo Aquino	12
13	Molecular and clinical evaluation of the acute human parvovirus B19 infection: comparison of two cases in children with sickle cell disease and discussion of the literature 2013 ·The Brazilian Journal of Infectious Diseases ·Svetoslav Nanev Slavov, Simone Kashima, (unknown), Alberto A. Amarilla, Víctor Hugo Aquino, Dimas Tadeu Covas	9
14	Phylogenetic relationship of dengue virus type 3 isolated in Brazil and Paraguay and global evolutionary divergence dynamics 2012 ·Virology Journal ·(unknown), Alberto A. Amarilla, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Pedro Fernando da Costa Vasconcelos, Deusilene Souza Vieira, (unknown), (unknown), Cynthia Vázquez, (unknown), Luíz Tadeu Moraes Figueiredo, Víctor Hugo Aquino	13
15	Detection of dengue virus in sera of Brazilian blood donors 2012 ·Transfusion ·(unknown), Alberto A. Amarilla, (unknown), Dimas Tadeu Covas, Víctor Hugo Aquino, Luíz Tadeu Moraes Figueiredo	43
16	Mosquitoes infected with dengue viruses in Brazil 2010 ·Virology Journal ·(unknown), Almério de Castro Gomes, Alberto A. Amarilla, André de Souza Leandro, (unknown), (unknown), (unknown), Edison Luíz Durigon, Víctor Hugo Aquino, (unknown)	71
17	Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization 2010 ·Biologicals ·Juliana Helena Chávez, Jaqueline Raymondi Silva, Alberto A. Amarilla, Luíz Tadeu Moraes Figueiredo	101
18	A simple one‐step real‐time RT‐PCR for diagnosis of dengue virus infection 2008 ·Journal of Medical Virology ·(unknown), (unknown), (unknown), Vanessa Danielle Menjon Müller, (unknown), (unknown), (unknown), Alberto A. Amarilla, (unknown), Márcio Roberto Teixeira Nunes, Samir Mansour Moraes Casseb, Pedro Fernando da Costa Vasconcelos, Soraya Jabur Badra, Luíz Tadeu Moraes Figueiredo, Víctor Hugo Aquino	32
19	Productividad científica del Paraguay en el área de biomedicina: un análisis bibliométrico 2007 ·Memorias del Instituto de Investigaciones en Ciencias de la Salud ·(unknown), Alberto A. Amarilla, Gabriel I. Parra	1
20	Diversity of group A rotavirus strains circulating in Paraguay from 2002 to 2005: Detection of an atypical G1 in South America 2007 ·Journal of Clinical Virology ·Gabriel I. Parra, Emilio E. Espínola, Alberto A. Amarilla, Juan A. Stupka, M. Martínez, (unknown), (unknown), (unknown), Graciela Russomando, Juan Arbiza	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact